Company profile: Raptor Pharma
1.1 - Company Overview
Company description
- Provider of biopharmaceutical therapeutics, engaging in discovery, research and preclinical development of drug candidates and drug-targeting platforms for brain and neurodegenerative diseases, genetic disorders and cancer, and commercializing TEPEZZA for Thyroid Eye Disease and UPLIZNA for neuromyelitis optica spectrum disorder in AQP4 antibody-positive adults.
Products and services
- Drug Discovery and Preclinical Development: Architects preclinical-stage drug candidates and drug-targeting platforms for brain disorders, neurodegenerative diseases, genetic disorders, and cancer, conducting discovery, research, and preclinical development in the United States
- TEPEZZA (teprotumumab-trbw): Delivers a rare-disease therapeutic for Thyroid Eye Disease (TED), an autoimmune condition affecting the eyes, used specifically for treatment and management of TED
- UPLIZNA (inebilizumab-cdon): Offers an adult-indicated therapeutic for neuromyelitis optica spectrum disorder (NMOSD) in anti-aquaporin-4 (AQP4) antibody positive patients, used to treat eligible adult NMOSD cases
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Raptor Pharma
IMGM Laboratories
HQ: Germany
Website
- Description: Provider of advanced genomic services via a service center in Martinsried, Germany for academic and industrial genome research, serving pharma, diagnostics, academia and biotech. Accredited to DIN EN ISO/IEC 17025 for gene expression analysis using Agilent microarrays and qPCR, and offering first-class NGS, metagenomic sequencing, biomarker discovery, pharmacogenetics, and qPCR/ddPCR-based biodistribution studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IMGM Laboratories company profile →
GenArraytion
HQ: United States
Website
- Description: Provider of medical diagnostics products and services for tick- and mosquito-borne disease and surveillance, epidemiology and source tracking, food and water testing, biodefense and environmental monitoring, including MultiFLEX Bioassays and Sniper Sequencing genotyping services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenArraytion company profile →
Immunostep
HQ: Spain
Website
- Description: Provider of flow chemistry products and services for diagnostic and research applications, including antibodies and conjugates, recombinant proteins, vials, staining solutions, and stability reagents, plus mono- and polyclonal development and peptide production. Offers kits for flow cytometry such as HeMoStep, apoptosis and basophil activation, platelet immunoglobulin and COVID-19 tests, and the ExoStep exosome platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunostep company profile →
PreventionGenetics
HQ: United States
Website
- Description: Provider of comprehensive genetic testing services, including whole-genome (PGnome) and whole-exome (PGxome) sequencing; targeted panels across endocrinology, hematology, and immunology; and Sanger sequencing, aCGH, and MLPA to detect and confirm genetic variants, deletions, and duplications across nearly all clinically relevant genes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PreventionGenetics company profile →
Provista Diagnostics
HQ: United States
Website
- Description: Provider of blood-based diagnostic tests focused on oncology, including Videssa Breast Cancer Test combining serum protein biomarkers and tumor-associated autoantibodies for high-accuracy detection in women with abnormal imaging findings. Also offers COVID-19 PCR testing with same-day results from car-based collection, Long COVID panel, FDA-EUA real-time qPCR respiratory tests, UTI PCR testing, and wound infection testing with antibiotic resistance assessment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Provista Diagnostics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Raptor Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Raptor Pharma
2.2 - Growth funds investing in similar companies to Raptor Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Raptor Pharma
4.2 - Public trading comparable groups for Raptor Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →